2017
DOI: 10.1016/j.brainres.2016.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Serine/threonine-kinase 33 (Stk33) – Component of the neuroendocrine network?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…STK33 gene encodes a novel serine/threonine protein kinase. Due to the specific structure, STK33 cannot only activate the protease but also participate in a variety of life activities by affecting absorption of calcium ( 15 ). STK33, as a newly discovered gene with unclear mechanism, has attracted increasing attention.…”
Section: Discussionmentioning
confidence: 99%
“…STK33 gene encodes a novel serine/threonine protein kinase. Due to the specific structure, STK33 cannot only activate the protease but also participate in a variety of life activities by affecting absorption of calcium ( 15 ). STK33, as a newly discovered gene with unclear mechanism, has attracted increasing attention.…”
Section: Discussionmentioning
confidence: 99%
“…STK33 belongs to a member of the calcium/calmodulin‐dependent kinase (CAMK), which is mainly existed in testis, certain brain regions and embryonic organs such as brain, heart and spinal cord in human and mouse and is likely to participate in spermatogenesis and organ ontogenesis . Studies show that STK33 is co‐localized with the intermediate filament protein vimentin in tanycytes of mouse, rat and hamster, which is involved in the dynamic changes of the intermediate filament cytoskeleton assembly/disassembly, and regulates the cell structure as well as a few important functions through the specific phosphorylation of vimentin . It is well known that apoptosis caused by STK33 suppression is mediated by the mitochondrial pathway, PI3K/AKT cascade or the mitogen‐activated protein kinases (MAPKs)‐signalling pathway …”
Section: Introductionmentioning
confidence: 99%
“…7,8 Studies show that STK33 is co-localized with the intermediate filament protein vimentin in tanycytes of mouse, rat and hamster, 9 which is involved in the dynamic changes of the intermediate filament cytoskeleton assembly/disassembly, and regulates the cell structure as well as a few important functions through the specific phosphorylation of vimentin. 10,11 It is well known that apoptosis caused by STK33 suppression is mediated by the mitochondrial pathway, PI3K/AKT cascade or the mitogen-activated protein kinases (MAPKs)-signalling pathway. 6 It has been documented that MAPKs, which are composed of a serine/threonine protein kinases, represent the classical signal transduction pathways.…”
Section: Introductionmentioning
confidence: 99%
“…STK33 is located on chromosome region 11p15.3; its entire functions have not been elucidated yet; however, there are some suggestions (Brauksiepe, Baumgarten, Reuss, & Schmidt, ). For example, Reuss, Brauksiepe, Disque‐Kaiser, & Olivier, evaluated the expression and presence of STK33 protein in neuronal structures of central nervous system in rats and hamsters and observed large STK33‐immunoreactive axonal projections from magnocellular hypothalamus to the neurohypophysis (Reuss et al, ). Hence, this functional connection suggests a bridge from neuronal to humoral regulation of the endocrine system.…”
Section: Discussionmentioning
confidence: 99%